Proteolytic release of the carboxy-terminal fragment of proHB-EGF causes nuclear export of PLZF
about
Heparin-binding EGF-like growth factor protects intestinal stem cells from injury in a rat model of necrotizing enterocolitis.Sequential and gamma-secretase-dependent processing of the betacellulin precursor generates a palmitoylated intracellular-domain fragment that inhibits cell growthProcessing of VEGF-A by matrix metalloproteinases regulates bioavailability and vascular patterning in tumorsHeparin-binding epidermal growth factor-like growth factor/diphtheria toxin receptor in normal and neoplastic hematopoiesisDiagnostic value of interleukin-8 in colorectal cancer: a case-control study and meta-analysisReversible interconversion and maintenance of mammary epithelial cell characteristics by the ligand-regulated EGFR system.An Integrative Analysis of Preeclampsia Based on the Construction of an Extended Composite Network Featuring Protein-Protein Physical Interactions and Transcriptional RelationshipsADAMs: key components in EGFR signalling and developmentTelmisartan inhibits cell proliferation by blocking nuclear translocation of ProHB-EGF C-terminal fragment in colon cancer cellsRegulation of heparin-binding EGF-like growth factor by miR-212 and acquired cetuximab-resistance in head and neck squamous cell carcinomaThe role of epidermal growth factor receptor (EGFR) signaling in SARS coronavirus-induced pulmonary fibrosis.Implication of intracellular localization of transcriptional repressor PLZF in thyroid neoplasms.ADAM-17: the enzyme that does it all.The expression of heparin-binding epidermal growth factor-like growth factor by regulatory macrophages.A mouse model of otitis media identifies HB-EGF as a mediator of inflammation-induced mucosal proliferation.The heparin-binding domain of HB-EGF mediates localization to sites of cell-cell contact and prevents HB-EGF proteolytic release.Smooth muscle α-actin is a direct target of PLZF: effects on the cytoskeleton and on susceptibility to oncogenic transformation.Nuclear translocation of the cytoplasmic domain of HB-EGF induces gastric cancer invasion.Heparin-binding epidermal growth factor-like growth factor as a novel targeting molecule for cancer therapy.A potent anti-HB-EGF monoclonal antibody inhibits cancer cell proliferation and multiple angiogenic activities of HB-EGFIdentification of the cancer cell proliferation and survival functions of proHB-EGF by using an anti-HB-EGF antibody.The Roles of ADAMs Family Proteinases in Skin DiseasesMembrane-anchored growth factors, the epidermal growth factor family: beyond receptor ligands.Amphiregulin carboxy-terminal domain is required for autocrine keratinocyte growth.The ADAMs family of proteases: new biomarkers and therapeutic targets for cancer?NLRP7, Involved in Hydatidiform Molar Pregnancy (HYDM1), Interacts with the Transcriptional Repressor ZBTB16.The promyelocytic leukemia zinc finger protein: two decades of molecular oncologyHeparin-binding EGF-like growth factor promotes epithelial-mesenchymal transition in human keratinocytes.Membrane-anchored growth factor, HB-EGF, on the cell surface targeted to the inner nuclear membraneMembrane-Tethered Intracellular Domain of Amphiregulin Promotes Keratinocyte Proliferation.The significance of disulfide bonding in biological activity of HB-EGF, a mutagenesis approach.BCL6 degradation caused by the interaction with the C-terminus of pro-HB-EGF induces cyclin D2 expression in gastric cancers.Intestinal phenotype in mice overexpressing a heparin-binding EGF-like growth factor transgene in enterocytes.The role of protease activity in ErbB biology.PLZF is a regulator of homeostatic and cytokine-induced myeloid developmentAnalysis of the interaction between Zinc finger protein 179 (Znf179) and promyelocytic leukemia zinc finger (Plzf).Ectodomain shedding and remnant peptide signalling of EGFRs and their ligands.When urothelial differentiation pathways go wrong: implications for bladder cancer development and progression.Essential roles of heparin-binding epidermal growth factor-like growth factor in the brain.Nuclear trafficking of secreted factors and cell-surface receptors: new pathways to regulate cell proliferation and differentiation, and involvement in cancers.
P2860
Q24629285-C2462037-E4B2-4A09-8B7A-F0059136EE4FQ24633569-03960AEE-67E7-4A38-B180-F69C5B2C2AD2Q24678647-08B3E6EF-10BB-454B-9344-571C9502036BQ26852845-66DFCEA4-F492-4485-BA3C-916F37AC312AQ27022726-A2D8575F-9BD7-4199-84D8-ADC5FB59E8D3Q27438184-8BC40BAA-E429-48F7-B372-D0FCC60547A4Q28109684-FEA5AC06-9237-472D-AE31-960897D0EDFDQ28305519-B8B7457B-B27E-4659-8585-2B62C7E81176Q28486669-076E67DC-BABC-41E0-B92E-5AD86959FBCDQ28749302-25069EB8-1875-4B07-83F3-E9B4C6D9958CQ30234893-013101CB-C4B2-4DA5-B4BC-5D18C458D3A5Q31170872-B3F5EE8D-0DEC-4928-8F18-64DC17E928CBQ33737421-729B1431-8B23-47FF-92F4-94E205F221DDQ33860043-07E14C3D-09B4-445F-B331-13C116AA5D61Q33916488-F7D61FFD-9630-4F56-BEDA-AB56C447D521Q33917661-B6173754-A535-4759-B501-4D54E686D55AQ33992903-85122AF4-01F7-4CC9-BE12-164007766CFBQ34286158-1415C312-9DE0-476B-8927-DA51B061A7C1Q34516136-3F4B1645-23D4-4D2B-84C7-08DC74A47071Q34517448-02139209-39FA-4EF2-A10C-0C3E8558C973Q34563226-E2F2D331-87AD-459E-A317-5FE247742D95Q34669802-C4FE670B-4289-4F29-B42D-83C840F55E61Q34749765-CAD4E8F7-B855-4CBB-A86B-A11C4A7C5ACFQ34773509-B38DF3D2-F3CA-466F-9152-7476D840C9CAQ35206311-92C314D4-CFDA-4E16-B399-82B905D2690FQ35677533-939D7CDB-30D7-4E20-A825-2130D9BE9C38Q36099642-51BCBF7A-6CA2-4DEA-B5A8-E9ED947DC1A8Q36177166-B8BB6B7A-BA9E-458A-88AD-9D83B1F04EF4Q36639032-C0BAF396-9A02-4D0D-B5D5-5A44A7D6B0A8Q36677686-401DAA9D-62D7-45DF-B3FE-1C0A0BA3EF62Q37077461-0B5B2CC3-2AD5-4D4E-A8F1-A2CCD5B2D97CQ37177907-B1985BC4-D16B-4835-A3A5-49F1245C051EQ37289601-DC0BCBE1-06C3-450D-8231-E47B87A4FAC3Q37326973-F5FAC916-C696-433C-A8C3-1A285A9B9C76Q37362806-AE4F82BB-6B2D-4474-9259-B05A4160983EQ37425770-710102E3-E631-4817-9188-BFC3141CD977Q37879318-F0A17F0D-450E-4197-B2D2-067ACE257B2DQ37933675-B125350A-90DC-4177-AF20-576448676A36Q38046005-EFF2A6D8-7BEA-4BDF-8F5E-420F2070CFF9Q38903941-B9B1F179-29CF-4A63-ACC2-9E8CAA4728F6
P2860
Proteolytic release of the carboxy-terminal fragment of proHB-EGF causes nuclear export of PLZF
description
2003 nî lūn-bûn
@nan
2003 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Proteolytic release of the car ...... causes nuclear export of PLZF
@ast
Proteolytic release of the car ...... causes nuclear export of PLZF
@en
Proteolytic release of the car ...... causes nuclear export of PLZF
@nl
type
label
Proteolytic release of the car ...... causes nuclear export of PLZF
@ast
Proteolytic release of the car ...... causes nuclear export of PLZF
@en
Proteolytic release of the car ...... causes nuclear export of PLZF
@nl
prefLabel
Proteolytic release of the car ...... causes nuclear export of PLZF
@ast
Proteolytic release of the car ...... causes nuclear export of PLZF
@en
Proteolytic release of the car ...... causes nuclear export of PLZF
@nl
P2093
P2860
P3181
P356
P1476
Proteolytic release of the car ...... causes nuclear export of PLZF
@en
P2093
Daisuke Nanba
Koji Hashimoto
Shigeki Higashiyama
P2860
P304
P3181
P356
10.1083/JCB.200303017
P407
P577
2003-11-10T00:00:00Z